In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

We recently published a list of 10 Best Stocks to Buy and Hold For 2025. In this article, we are going to take a look at ...

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

For surgeons already split on their preference of inhaled pulmonary vasodilator to prevent postoperative right ventricular ...

Annual Meeting, researchers presented risk-adjusted findings that shed new light on treatments for severe emphysema.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.